TECVAYLI sol inj 30 mg/3ml flac 3 ml
7680687470018
CH-68747
L01FX24
07.16.1.
Reimbursement limitations:
TECVAYLI
Après garantie de prise en charge des coûts par l’assureur-maladie après consultation préalable du médecin-conseil.
…
1 / 3
google
Details
- Product number
- 6874701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- teclistamabum 30 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 0.75 mg.
Articles (1)
Tecvayli 30 mg/3 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.75 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 853.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 68747
- Drug name
- Tecvayli, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FX24
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 22/12/2022
- Authorization expiration date
- 30/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TECVAYLI sol inj 30 mg/3ml flac 3 ml
- Description (DE)
- TECVAYLI Inj Lös 30 mg/3ml Durchstf 3 ml
- Market launch
- 22/12/2022
- Narcotic (BTM)
- No